FTRE (Fortrea Holdings) Current Deferred Revenue: $481 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FTRE Fortrea Holdings Inc FTRE
65 GF Score
Price $20.70
GF Value $18.16
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Fortrea Holdings Current Deferred Revenue?

Fortrea Holdings FTRE +7.81% 65 Current Deferred Revenue is $481 Mil as of Mar. 2026. GuruFocus rates FTRE with a GF Score™ of 65/100 and a GF Value™ of $18.16 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Fortrea Holdings's current deferred revenue for the quarter that ended in Mar. 2026 was $481 Mil.

Fortrea Holdings Current Deferred Revenue Related Terms

Fortrea Holdings Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Fortrea Holdings's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortrea Holdings Current Deferred Revenue Chart

Fortrea Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial 307.00 271.50 214.20 353.30 473.80

Fortrea Holdings Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 364.40 381.70 411.60 473.80 481.30
FTRE
65GF Score
Fortrea Holdings Inc FTRE
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of $481 Mil mean?
Fortrea Holdings (FTRE) has a Current Deferred Revenue of $481 Mil as of Mar. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Fortrea Holdings and its competitors.
Is Fortrea Holdings' Current Deferred Revenue too high?
Fortrea Holdings' current Current Deferred Revenue is $481 Mil. Overall, Fortrea Holdings has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fortrea Holdings' Current Deferred Revenue compare to SNDX and KARD?
Fortrea Holdings' Current Deferred Revenue of $481 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Biotechnology company?
A good Current Deferred Revenue depends on the Biotechnology industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Fortrea Holdings and its competitors. Fortrea Holdings's current Current Deferred Revenue is $481 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortrea Holdings stock overvalued right now?
Based on GuruFocus' analysis, Fortrea Holdings (FTRE) is currently considered Modestly Overvalued. The stock's GF Value™ is $18.16, compared to a current price of $20.70 — trading 14% above its estimated fair value. The current Current Deferred Revenue is $481 Mil. Fortrea Holdings' overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Fortrea Holdings (FTRE), the current Current Deferred Revenue is $481 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortrea Holdings (FTRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fortrea Holdings stock appears to be overvalued. The current stock price of $20.70 is trading 14% above its estimated GF Value™ of $18.16. GuruFocus considers Fortrea Holdings to be Modestly Overvalued.

Key valuation signals for FTRE:

  • Current Deferred Revenue: $481 Mil
  • GF Value™: $18.16 vs. price of $20.70 (14% above fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the FTRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortrea Holdings Business Description

Other Exchanges K67:Germany
Address 8 Moore Drive, Durham, NC, USA, 27713
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
65GF Score

Get the complete analysis for FTRE

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.70
Price
$18.16
GF Value